2014 Hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations

Journal of the American College of Cardiology

Volumn 64, Issue 4, 2014, Pages 394-402

  Krakoff, Lawrence R ^a   Gillespie, Robert L ^b   Ferdinand, Keith C ^c   Fergus, Icilma V ^d   Akinboboye, Ola ^e   Williams, Kim A ^f   Walsh, Mary Norine ^g   Bairey Merz, C Noel ^h   Pepine, Carl J ⁱ  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Sharp Rees Stealy Medical Group   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e Queens Heart Institute   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g St Vincent Heart Center of Indiana   (United States)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

Author keywords

hypertension and prevention hypertension; quality of care and outcomes assessment appropriateness; quality of care and outcomes assessment quality of care

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL;

ADVERSE OUTCOME; AFRICAN AMERICAN; AGED; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; GERIATRIC CARE; GERIATRIC PATIENT; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MENTAL STRESS; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RACISM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; URBAN AREA; WOMEN'S HEALTH;

HYPERTENSION AND PREVENTION/HYPERTENSION; QUALITY OF CARE AND OUTCOMES ASSESSMENT/APPROPRIATENESS; QUALITY OF CARE AND OUTCOMES ASSESSMENT/QUALITY OF CARE;

AFRICAN AMERICANS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COMMITTEE MEMBERSHIP; FEMALE; HUMANS; HYPERTENSION; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; WOMEN'S HEALTH;

EID: 84904888528     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.014     Document Type: Review

References (57)

1. A.V. Chobanian, G.L. Bakris, and H.R. Black et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
2. G.H. Gibbons, S.B. Shurin, and G.A. Mensah et al. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute Circulation 128 2013 1713 1715
3. A.S. Go, M.A. Bauman, and S.M. King et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention J Am Coll Cardiol 63 2014 1230 1238
4. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension, of the European Society of Cardiology 2013 ESH/ESC guidelines for the management of arterial hypertension Eur Heart J 34 2013 2159 2219
5. M.A. Weber, E.L. Schiffrin, and W.B. White et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension J Hypertens 32 2014 3 15
6. P.A. James, S. Oparil, and B.L. Carter et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2013 507 520
7. J.T. Wright Jr., L.J. Fine, and D.T. Lackland et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view Ann Intern Med 160 2014 499 503
8. Report of the Joint National Committee on Detection and Treatment of Hypertension JAMA 237 1977 261
9. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 140 1980 1280 1285
10. Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure. The 1984 report of the Joint National Committee on Detection and Treatment of Hypertension Arch Intern Med 144 1984 1045 1057
11. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure The 1988 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure Arch Intern Med 148 1988 1023 1038
12. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255 3264
13. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure The 5th report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V) Arch Intern Med 153 1993 154 183
14. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 157 1997 2413 2445
15. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
16. American Diabetes Association Position statement: standards of medical care in diabetes in 2013 Diabetes Care 36 Supp 1 2013 S11 66
17. N.S. Beckett, R. Peters, A.E. Fletcher HYVET Study Group Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 2008 1887 1898
18. P. Verdecchia, J.A. Staessen, and F. Angeli et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial Lancet 374 2009 525 533
19. JATOS Study Group Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) Hypertens Res 31 2008 2115 2127
20. T. Ogihara, T. Saruta, and H. Rakugi et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study Hypertension 56 2010 196 202
21. G.S. Panjrath, S. Chaudhari, and F.H. Messerli The j-point phenomenon in aggressive therapy of hypertension: new insights Curr Atheroscler Rep 14 2012 124 129
22. E.P. Vamos, M. Harris, and C. Millett et al. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study BMJ 345 2012 e5567
23. M. Banach, and W.S. Aronow Blood pressure j-curve: current concepts Curr Hypertens Rep 14 2012 556 566
24. J. Sundstrom, R. Sheikhi, and C.J. Ostgren et al. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients J Hypertens 31 2013 1603 1610
25. A.M. Navar-Boggan, M.J. Pencina, and K. Williams et al. Proportion of US adults potentially affected by the 2014 hypertension guideline JAMA 2014 Mar 29 [E-pub ahead of print]
26. E.S. Ford Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among US adults from 1999 to 2010 J Am Coll Cardiol 61 2013 2249 2252
27. J. Chen, S.L. Normand, Y. Wang, and H.M. Krumholtz National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries 1998 to 2008 JAMA 306 2011 1669 1678
28. C.D. Fryar, T. Chen, and X. Li Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010 NCHS Data Brief 103 2012 1 8
29. A.S. Go, D. Mozaffarian, and V.L. Roger et al. Heart disease and stroke statistics-2013 update: a report from the AHA Circulation 127 2013 e6 e245
30. I. Sipahi, A. Swaminathan, and V. Natesan et al. Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials Stroke 43 2012 432 440
31. S. Czernichow, A. Zanchetti, Turnbull Blood Pressure Lowering Treatment Trialists' Collaboration The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials J Hypertens 29 2011 4 16
32. J.M. Flack, D.A. Sica, and G. Bakris et al. Management of high blood pressure in African Americans: management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks Consensus Statement Hypertension 56 2010 780 800
33. G. Mancia, R. Fagard, and K. Narkiewicz et al. 2013 ESH/ESC guidelines for the management of arterial hypertension J Hypertens 31 2013 1281 1357
34. D.G. Hackam, R.R. Quinn, and P. Ravani et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension Can J Cardiol 29 2013 528 542
35. National Institute for Health and Clinical Excellence Hypertension: clinical management of primary hypertension in adults 2011 National Institute for Health and Clinical Excellence London
36. W.S. Aronow, J.L. Fleg, and C.J. Pepine et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the ACC Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 57 2011 2037 2114
37. K.L. Ong, A.W. Tso, and K.S. Lam et al. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension Hypertension 51 2008 1142 1148
38. D. Levy, M.G. Larson, and R.S. Vasan et al. The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
39. T. Nwankwo, S.S. Yoon, and V. Burt et al. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012 NCHS Data Brief 133 2013 1 8
40. V. Schächinger, M.B. Britten, and A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
41. C. Bushnell, L.D. McCullough, and I.A. Awad et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 45 2014 1545 1588
42. Q. Gu, V.L. Burt, and R. Paulose-Ram et al. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004 Am J Hypertens 21 2008 789 798
43. R.S. Vasan, M.G. Larson, and E.P. Leip et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study Lancet 358 2001 1682 1686
44. R.S. Vasan, A. Beiser, and S. Seshadri et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study JAMA 287 2002 1003 1010
45. F. Gueyffier, F. Boutitie, J.P. Boissel The INDANA Investigators Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials Ann Intern Med 126 1997 761 767
46. K. Jamerson, M.A. Weber, and G.L. Bakris et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients New Engl J Med 359 2008 2417 2428
47. B. Neal, S. MacMahon, N. Chapman Blood Pressure Lowering Treatment Trialists' Collaboration Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials Lancet 356 2000 1955 1964
48. S.I. Chaudhry, H.M. Krumholz, and J.M. Foody Systolic hypertension in older persons JAMA 292 2004 1074 1080
49. P. Ong, A. Athanasiadis, and G. Borgulya et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries: the ACOVA study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries) J Am Coll Cardiol 59 2012 655 662
50. K.C. Ferdinand Management of high blood pressure in African Americans and the 2010 ISHIB consensus statement: meeting an unmet need J Clin Hypertens 12 2010 237 239
51. Veterans Administration Cooperative Study Group on Antihypertensive Agents Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg JAMA 202 1967 1028 1034
52. Hypertension Detection and Follow-up Program: Cooperative Group Five-year findings of the Hypertension Detection and Follow-up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension JAMA 242 1979 2562 2571
53. Medical Research Council Working Party MRC trial of treatment of mild hypertension: principal results BMJ 291 1985 97 104
54. Untreated mild hypertension: a report by the management committee of the Australian Therapeutic Trial in Mild Hypertension Lancet 1 1982 185 191
55. J.A. Staessen, R. Fagard, and L. Thijs et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension Lancet 350 1997 757 764
56. B.M. Brenner, M.E. Cooper, and D. de Zeeuw et al. Effects of losartan on renal and cardiovascular outcomes in patients with type-2 diabetes and nephropathy N Engl J Med 345 2001 861 869
57. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type-2 diabetes N Engl J Med 345 2001 851 860